show episodes
 
The Bipartisan Commission on Biodefense is a privately funded entity established in 2014 to provide for a comprehensive assessment of the state of U.S. biodefense efforts and to issue recommendations that will foster change. From 2014-2015, the Commission convened four public meetings in Washington, DC on biological threat awareness, prevention and protection, surveillance and detection, and response and recovery. Current and former Members of Congress, former Administration officials, state ...
 
Loading …
show series
 
Seven years after the release of the Commission’s National Blueprint for Biodefense, the Nation remains critically unprepared for future biological events, which threaten to strain resources and impact government efforts to address threats like COVID-19. At this meeting, the Commission intends to further explore challenges for biodefense response, …
 
On Thursday, September 22, 2022 the Commission held an in-person meeting - Banding Together: Partnerships for Biodefense. The Commission delved into how to optimize partnerships to defend against biological threats, a critical enabler of success identified in its report released earlier this year, The Athena Agenda: Advancing The Apollo Program for…
 
On Tuesday, May 3, 2022 the Commission convened an in-person meeting to provide the Bipartisan Commission on Biodefense with a better understanding of: (1) biological incidents that affect homeland and national security; (2) roles and responsibilities of the Department of Homeland Security (DHS) in addressing biological threats; and (3) opportuniti…
 
On Tuesday, March 22, 2022, the Commission convened for an in-person meeting to provide a better understanding of: (1) the expanding landscape of current and future biological threats; (2) the roles and responsibilities of the federal government in assess and preparing for various biological threats; and (3) biological weapons, bioterrorism, and bi…
 
The Commission’s baseline 2015 report, A National Blueprint for Biodefense: Leadership and Major Reform Needed to Optimize Efforts, warned that the United States was inadequately prepared for biological threats. Six years later, the U.S. experience with COVID-19 continues to validate our original findings. The Commission’s January 2021 report, The …
 
In its 2015 report, A National Blueprint for Biodefense: Leadership and Major Reform Needed to Optimize Efforts, the Commission addressed inadequacies of BioWatch, the Department of Homeland Security environmental biodetection program. Established in 2003, the federal government intended for BioWatch to provide early warning of biological attacks o…
 
NOTE: This event was prerecorded on June 15, 2021. In its 2015 report, A National Blueprint for Biodefense: Leadership and Major Reform Needed to Optimize Efforts, the Commission identified the need to safeguard pathogen and advanced biotechnology information against cyber-attacks and illicit access. Due to the increasing convergence of cyber and b…
 
On March 23, 2021, we premiered a virtual meeting of the Commission to further explore the of the first responder community and how the federal government can better support non-federal response to future biological incidents. The Commission’s 2018 report, Holding the Line on Biodefense: State, Local, Tribal, and Territorial Reinforcements Needed, …
 
On September 24, 2020, we premiered a virtual meeting of the Commission to address emerging biological threats and innovative science and technology solutions to address them. The ongoing novel coronavirus 2019 (COVID-19) pandemic is revealing major gaps in national readiness to prepare for, respond to, and recover from biological threats. Decision…
 
On July 21, 2020, the Commission premiered   a virtual meeting to help us better understand the potential for COVID-19’s reemergence, the country’s efforts to track the spread of the disease, and national readiness to address future biological threats. More information about this meeting, including a full agenda, is available here.…
 
On May 8, 2020, we premiered a virtual meeting of the Commission to better understand the ongoing response to novel coronavirus 2019, national readiness to address possible large-scale spread of the disease in the United States and throughout the world, and implications for improving preparedness for the next biological threat. More information abo…
 
On Wednesday, February 12th, U.S. Senate Committee on Homeland Security and Governmental Affairs held a roundtable hearing titled, “Are we Prepared? Protecting the U.S. from Global Pandemics.” The purpose of this roundtable was to examine the nation’s level of preparedness against current and future pandemic threats, particularly in the context of …
 
On Monday, February 10th, the Bipartisan Commission on Biodefense and Hudson Institute hosted a panel discussion on the ongoing coronavirus outbreak and how the United States can respond to the growing outbreak effectively. More information about this meeting is available here.By Bipartisan Commission on Biodefense
 
On November 5, 2019, the Bipartisan Commission on Biodefense convened a meeting to inform its continuing assessment of the biological threat, specific vulnerabilities, and overwhelming consequences to agricultural producers. Speakers shared their perspectives, experiences, challenges, and recommended solutions with regard to agrodefense, and talked…
 
This meeting was held on September 17, 2019, to inform our continuing assessment of the biological threat, specific vulnerabilities, and overwhelming consequences. Topics discussed at this meeting included: The convergence of cyber- and biological sciences; The vulnerability of pathogen and biomanufacturing data systems; Biological risk mitigation;…
 
This meeting was held on July 11, 2019, to discuss A Manhattan Project for Biodefense – a national, public-private research and development undertaking to defend the Nation against biological threats. More information about this meeting, including a full agenda, is available here.By Bipartisan Commission on Biodefense
 
Max Brooks, the best-selling author of “World War Z” and non-resident fellow at the Modern War Institute at West Point, has partnered with the Blue Ribbon Study Panel on Biodefense on GERM WARFARE: A Very Graphic History. This highly stylized and engaging graphic novel reminds us never to take public health for granted. It’s all part of an effort b…
 
This meeting was held on February 5, 2019, and examined the responsibilities and requirements for federal biodefense efforts that are unique to the U.S. Department of Defense. More information about this meeting, including a full agenda, is available here.By Bipartisan Commission on Biodefense
 
This meeting was held on November 14, 2018, and examined how far the Executive Branch has come in implementing the National Blueprint for Biodefense. More information about this meeting, including a full agenda, is available here.By Bipartisan Commission on Biodefense
 
This meeting was held on October 9, 2018, and reexamined the anthrax events of 2001, as well as subsequent biological events to discuss where we are now and what else we need to do to ensure national biodefense. More information about this meeting, including a full agenda, is available here.By Bipartisan Commission on Biodefense
 
This meeting was held on July 31, 2018, and addressed private sector roles and responsibilities before, during, and after the response to large-scale biological events. More information about this meeting, including a full agenda, is available here.By Bipartisan Commission on Biodefense
 
This meeting was held on January 17, 2018, and addressed the ability of state, local, tribal, and territorial (SLTT) governments to respond to large-scale biological events. More information about this meeting, including a full agenda, is available here.By Bipartisan Commission on Biodefense
 
This meeting was held on November 2, 2017 and addressed implementation of the National Biodefense Strategy and its implications for the Office of Management and Budget, congressional authorization and appropriation, leadership, coordination, collaboration, and innovation. More information about this meeting, including a full agenda, is available he…
 
This meeting was held on October 3, 2017 and addressed the current states of science, investigations, and intelligence for biological attribution and the extent to which they inform strategic, operational, and tactical decisions. Federal government, industry, and academic representatives discussed their perspectives, experiences, challenges, and re…
 
On May 1, 2017, experts in biodefense and budget issues gathered to provide Commission Members with an understanding of and recommendations regarding leadership, interagency coordination, and risk challenges to biodefense budgeting. More information on this meeting, including a full agenda, is available here.…
 
Members of the Bipartisan Commission on Biodefense discuss the growing pandemic threat and the steps the United States government needs to take in order to keep America safe. Their discussion is moderated by Max Brooks (scholar and author of World War Z). This discussion took place on May 1, 2017 at the National Press Club in Washington, DC. See he…
 
This meeting of the Commission took place on January 26, 2017, and covers challenges and solutions for agrodefense. See here for more information on this event. Congressional Perspective The Honorable Roger Marshall, United States Representative, Kansas Panel One – Prevention and Deterrence Stephen Higgs, PhD, Associate Vice President for Research …
 
Testimony to House Committee on Armed Services The subcommittee on Emerging Threats and Capabilities of the House Committee on Armed Services held a hearing entitled, “Outside Views on Biodefense for the Department of Defense” and Commissioner Honorable Kenneth Wainstein and Commission Ex Officio member Dr. Gerald Parker served as witnesses. Their …
 
Testimony to House Committee on Homeland Security Former Senator Lieberman and Former Governor Ridge, the Commission's Co-Chairs, update Committee Members on the Commission's work and the state of U.S. biosecurity leadership and programs, including recommendations for improving our biodefense posture. This hearing took place on November 3, 2015. Se…
 
This meeting of the Commission took place on April 1, 2015, and covers response and recovery needs for biodefense. See here for more information on this event. Objective: Provide panelists with an understanding of the biodefense requirements for effective preparedness, response and recovery from biological and chemical threats that can inflict pote…
 
This meeting of the Commission took place on March 12, 2015. See here for more information on this event. Panel One: The Biosurveillance and Detection Landscape Discussion of key elements of effective biosurveillance and detection, and continued challenges in the effectiveness of ongoing efforts. Dr. Julie Gerberding, Executive Vice President for S…
 
This meeting of the Commission took place on January 14, 2015. See here for more information on this event. Panel One: Biological Arms Control, Cooperative Threat Reduction, Global Health Security Agenda, and Quarantine Dr. David R. Franz (via internet video) Dr. Dan Gerstein Dr. Beth Cameron Dr. Mike Stoto Working Lunch: First Responder Protection…
 
Loading …

Quick Reference Guide

Copyright 2023 | Sitemap | Privacy Policy | Terms of Service